BreakingAscend and LGE Credit Unions to merge in $7B dealRead now →

Acquirer Profile

Amneal Pharmaceuticals

Amneal Pharmaceuticals Acquisitions & Deals (2026)

Biosimilars

Deals tracked

1

Primary sector

Biosimilars

Active

2026

David Najork
Tracked by ·FireStrike Deal Intelligence··@FireStrikeNews

FireStrike tracks every Amneal Pharmaceuticals acquisition, merger, and strategic investment in real time. This page covers 1 Amneal Pharmaceuticals deals, spanning Biosimilars. Data covers 2026.

Amneal Pharmaceuticals Acquisitions — Full List

Target companyAnnouncedSource
Apr 2026

Amneal Pharmaceuticals Acquisitions — FAQ

How many acquisitions has Amneal Pharmaceuticals made?

Amneal Pharmaceuticals has made 1 acquisitions and deals tracked on FireStrike.

What sectors does Amneal Pharmaceuticals acquire in?

Amneal Pharmaceuticals primarily acquires in Biosimilars.

What is Amneal Pharmaceuticals's most recent acquisition?

Amneal Pharmaceuticals's most recent tracked acquisition is Kashiv BioSciences, announced Apr 2026.

Get every Amneal Pharmaceuticals deal in your inbox

FireStrike tracks M&A, IPOs, and fundraises daily — free.

Start tracking free →
FireStrikeFireStrike

Deal intelligence for M&A, mergers, IPOs, and funding rounds — sourced from primary filings and press, updated continuously.

© 2026 FireStrikeEvery deal. Every day.